Pulse Biosciences Inc
F:6L8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Pulse Biosciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pulse Biosciences Does
Pulse Biosciences develops medical technology that uses very short electrical pulses to destroy unwanted tissue without the heat and mechanical damage of traditional ablation tools. Its main product work centers on systems for treating skin conditions and other soft tissue targets, using a method the company calls nanosecond pulsed field ablation.
- Headquarters
- United States of America US
- Employees
- 116
- IPO date
- May 18, 2016
Balance Sheet
Recent Events
Latest Earnings Call
Pulse Biosciences completed Nano-Pulse AF enrollment ahead of schedule and is shifting toward pre-commercial readiness while advancing its clinical programs.
Open the earnings call- EPS
- −$0.32
- Expected
- −$0.35
- Surprise
- +8.6%
- Stock, next trading day
- +0.4%
Pulse Biosciences insiders are buying within their usual range
Past 12 months
Continue 6L8 Research
Decided on Pulse Biosciences? Get an email when 6L8 reaches the price you’d buy at. Free with an account.